Search research articles
Contact Us
Filters
Showing results (1-10 of 95) with videos related to
Page
of 10
Sort By:
Current Opinion in Rheumatology
|
December 20, 2012
The interferon signature in autoimmune diseases
Lars Rönnblom, Maija-Leena Eloranta
Journal of Molecular Medicine (Berlin, Germany)
|
April 21, 2016
Cause and consequences of the activated type I interferon system in SLE
Maija-Leena Eloranta, Lars Rönnblom
Autoimmunity
|
October 9, 2009
Endogenous type I interferon inducers in autoimmune diseases
Doreen Finke, Maija-Leena Eloranta, Lars Rönnblom
Current Pharmaceutical Biotechnology
|
January 3, 2012
Primary Sjögren's syndrome and the type I interferon system
Gunnel Nordmark, Maija-Leena Eloranta, Lars Ronnblom
Seminars in Immunology
|
February 5, 2011
The type I interferon system in the development of lupus
Lars Rönnblom, Gunnar V Alm, Maija-Leena Eloranta
Current Opinion in Rheumatology
|
June 16, 2009
Type I interferon and lupus
Lars Rönnblom, Gunnar V Alm, Maija-Leena Eloranta
Autoimmunity
|
February 27, 2004
Role of natural interferon-alpha producing cells (plasmacytoid dendritic cells) in autoimmunity
Lars Rönnblom, Maija-Leena Eloranta, Gunnar V Alm
Scandinavian Journal of Immunology
|
March 29, 2020
Activation of plasmacytoid dendritic cells and B cells with two structurally different Toll-like receptor 7 agonists
Olof Berggren, Pascal Pucholt, Cane Amcoff, et al.
Arthritis Research & Therapy
|
June 7, 2020
The regulation and pharmacological modulation of immune complex induced type III IFN production by plasmacytoid dendritic cells
Karin Hjorton, Niklas Hagberg, Pascal Pucholt, et al.
The Science of the Total Environment
|
February 16, 2002
Effects of coxsackievirus B3 infection on the acute-phase protein metallothionein and on cytochrome P-4501A1 involved in the detoxification processes of TCDD in the mouse
Eva Funseth, Martin Påhlman, Maija-Leena Eloranta, et al.
Page
of 10
Search research articles
Search
Showing results (1-10 of 95) with videos related to
Sort By:
Page
of 10
Current Opinion in Rheumatology
|
December 20, 2012
The interferon signature in autoimmune diseases
Lars Rönnblom, Maija-Leena Eloranta
Journal of Molecular Medicine (Berlin, Germany)
|
April 21, 2016
Cause and consequences of the activated type I interferon system in SLE
Maija-Leena Eloranta, Lars Rönnblom
Autoimmunity
|
October 9, 2009
Endogenous type I interferon inducers in autoimmune diseases
Doreen Finke, Maija-Leena Eloranta, Lars Rönnblom
Current Pharmaceutical Biotechnology
|
January 3, 2012
Primary Sjögren's syndrome and the type I interferon system
Gunnel Nordmark, Maija-Leena Eloranta, Lars Ronnblom
Seminars in Immunology
|
February 5, 2011
The type I interferon system in the development of lupus
Lars Rönnblom, Gunnar V Alm, Maija-Leena Eloranta
Current Opinion in Rheumatology
|
June 16, 2009
Type I interferon and lupus
Lars Rönnblom, Gunnar V Alm, Maija-Leena Eloranta
Autoimmunity
|
February 27, 2004
Role of natural interferon-alpha producing cells (plasmacytoid dendritic cells) in autoimmunity
Lars Rönnblom, Maija-Leena Eloranta, Gunnar V Alm
Scandinavian Journal of Immunology
|
March 29, 2020
Activation of plasmacytoid dendritic cells and B cells with two structurally different Toll-like receptor 7 agonists
Olof Berggren, Pascal Pucholt, Cane Amcoff, et al.
Arthritis Research & Therapy
|
June 7, 2020
The regulation and pharmacological modulation of immune complex induced type III IFN production by plasmacytoid dendritic cells
Karin Hjorton, Niklas Hagberg, Pascal Pucholt, et al.
The Science of the Total Environment
|
February 16, 2002
Effects of coxsackievirus B3 infection on the acute-phase protein metallothionein and on cytochrome P-4501A1 involved in the detoxification processes of TCDD in the mouse
Eva Funseth, Martin Påhlman, Maija-Leena Eloranta, et al.
Page
of 10